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Mammalian cells present a fingerprint of their proteome to the
adaptive immune system through the display of endogenous peptides
on MHC-I complexes. MHC-I−bound peptides originate from protein
degradation by the proteasome, suggesting that stably folded, long-
lived proteins could evade monitoring. Here, we investigate the role
in antigen presentation of the ribosome-associated quality control
(RQC) pathway for the degradation of nascent polypeptides that are
encoded by defective messenger RNAs and undergo stalling at the
ribosome during translation. We find that degradation of model pro-
teins by RQC results in efficient MHC-I presentation, independent
of their intrinsic folding properties. Quantitative profiling of MHC-I
peptides in wild-type and RQC-deficient cells by mass spectrometry
showed that RQC substantially contributes to the composition of the
immunopeptidome. Our results also identify endogenous substrates
of the RQC pathway in human cells and provide insight into common
principles causing ribosome stalling under physiological conditions.
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The major histocompatibility complex (MHC) molecules playa central role in the vertebrate adaptive immune system.
MHC class I binds to short peptides (8 to 11 amino acids long)
sampled from the proteolytic products of intracellular proteins.
MHC-I−loaded peptides are presented at the cell surface, where
they are surveyed by CD8+ T cells for the presence of non−self-
peptides (1). This system, present in all nucleated cells of higher
vertebrates, enables the recognition of cells infected with viruses
and other intracellular parasites, or cells accumulating aberrant
proteins resulting from malignant transformation. The presented
peptides originate mostly from degradation by the ubiquitin−
proteasome system (2, 3), which is responsible for the controlled
turnover of the great majority of cellular proteins, and for the
rapid degradation of defective species (4). The immune response
is remarkably efficient. In cultured cells, CD8+ T cells can rec-
ognize infected cells in less than 60 min after viral penetration
(5), despite the fact that viral proteins are usually very stable and
have slow turnover rates (6). Accordingly, cells require a mech-
anism for rapidly generating peptides from long-lived viral pro-
teins synthesized upon infection.
To explain the kinetic discrepancy between protein half-life
and MHC-I presentation, defective ribosomal products (DRiPs)
have been proposed to act as a significant source of self-peptides
and viral peptides. DRiPs were defined as proteins that do not
reach mature (stable) conformation and, unable to fold or as-
semble correctly, are targeted for rapid proteasomal degradation
(7). The DRiP designation later evolved to include errors in
transcription, splicing, and translation (8). While estimates for the
fraction of rapidly degraded newly synthesized proteins varied
considerably (6, 9–13), it has also been suggested that proteasome
substrates differ in their access to MHC-I presentation, with “true
DRiPs” undergoing privileged processing for presentation (14,
15). Therefore, one appealing notion of the DRiP hypothesis is
that production of an antigenic peptide would depend largely on
the rate of translation of the corresponding protein, and less on its
relative abundance or turnover once folded and assembled. This
would be particularly important for viral proteins, which constitute
only a minute fraction of the total cellular pool of proteins at the
early stages of infection (7). A number of studies showed that
presentation of certain model proteins is inefficient in the absence
of active synthesis, despite the presence of a large pool of mature
forms being degraded (16–18), while others reported productive
presentation of mature proteins (19, 20). The mechanism of DRiP
generation and the overall contribution of DRiPs to antigen
presentation remain areas of active research.
Here, we test the hypothesis that the ribosome-associated
quality control (RQC) machinery may play a role in MHC-I
antigen presentation. RQC is a conserved eukaryotic pathway
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that removes nascent polypeptide chains from ribosomes that
have stalled during translation (21) and thus qualify as DRiPs. In
contrast to quality control mechanisms that monitor the folding
state of newly synthesized polypeptides, RQC senses the state of
translation (22). RQC comprises five steps: sensing of elongation
stalling, ribosome splitting and messenger RNA (mRNA) dis-
sociation, assembly of the RQC machinery on the 60S subunit,
ubiquitylation of the nascent chain, and its extraction for pro-
teasomal degradation. The core components of the RQC ma-
chinery in mammals are the ubiquitin ligase Listerin (23) and the
factors NEMF and TCF25 (respectively, Ltn1/Rqc2/Rqc1 in
yeast) (21, 22, 24). NEMF/Rqc2 recognizes the peptidyl−transfer
RNA moiety at the interface of the dissociated 60S ribosome and
recruits Listerin/Ltn1 (24, 25), which mediates ubiquitylation of
the stalled polypeptide near the ribosome exit tunnel (25–27).
RQC is intimately linked to two mRNA degradation pathways
that take place in the cytoplasm: nonstop mRNA decay (28) and
no-go decay (29), which recognize mRNAs that lack stop codons
and mRNAs that present obstacles to elongation, respectively.
The resulting nascent protein is truncated and/or mutated and
therefore likely to be dysfunctional, but not necessarily mis-
folded. The RQC pathway ensures that these aberrant species
are committed to degradation. Although it evolved earlier than
the adaptive immune system, the RQC pathway has many ap-
pealing characteristics for a coopted function in MHC-I antigen
presentation. RQC-mediated degradation is comprehensive, as
stalling can occur for mRNAs of any gene. In addition, it is
folding-unbiased, as, according to current understanding, the
mRNA properties are critical for RQC recruitment and not the
folding state of the nascent chain. Finally, in line with the DRiP
hypothesis, degradation by the RQC machinery acts on actively
translated proteins rather than the existing protein pool.
Here we used model proteins to show that the RQC ma-
chinery generates antigenic peptides from nascent chains enco-
ded by defective mRNA molecules, and that folding to a stable
structure does not allow nascent chains to escape from RQC-
mediated presentation. Furthermore, we assess the contribution
of RQC degradation to antigen presentation under normal
growth conditions by profiling the MHC-I−bound peptidome of
wild-type (WT) and Listerin knockout (KO) cells by mass spec-
trometry (MS). The results demonstrate that RQC degradation
substantially influences the composition of the immunopepti-
dome. Our analysis also provides a dataset of natural RQC
degradation substrates in human cells, providing insights into this
still largely uncharacterized degradation pathway.
Results
Characterization of Model Proteins for RQC-Mediated Antigen
Presentation. To assess the potential of the RQC pathway to gen-
erate antigenic peptides, we designed model proteins that can be
directed to either RQC-mediated or misfolding-induced degrada-
tion. To this end, we employed destabilizing domains (DDs), small
protein domains designed to be unfolded and rapidly degraded but
stabilized in the presence of a cell-permeable ligand (30, 31) (Fig.
1A), thus allowing control of folding status. The FKBPDD (32)
and the DHFRDD (33) DDs, responsive to the Shield1 and tri-
methoprim ligands, respectively, were fused to the antigenic pep-
tide SIINFEKL and eGFP (Fig. 1A). The SIINFEKL sequence
from ovalbumin allows us to monitor presentation using the well-
characterized monoclonal antibody mAb 25-D1.16 (34), which
specifically recognizes SIINFEKL-bound murine MHC-I complex
H-2Kb. To create versions of these constructs directed to RQC
degradation, we removed the stop codons of the respective genes
(Fig. 1A). Expression of the nonstop (NS) model proteins results
in translation into the 3′UTR and polyadenylation tail, the latter
causing ribosomes to stall (35, 36). The DD-SIINFEKL-GFP
STOP and NS fusion proteins were introduced into the HeLa.Kb
cell line (37) that stably expresses the mouse H-2Kb MHC-I protein.
Experiments were performed using stable monoclonal cell lines for
each construct in WT and in RQC-deficient (Listerin-KO) cells
obtained by CRISPR/Cas (SI Appendix, Fig. S1). Cycloheximide
(CHX) chase experiments confirmed that both DD fusions (STOP
versions) were stable in the presence of ligand (half-life of >9 h),
but rapidly degraded in the absence of ligand, with a half-life of
∼4 h for FKBP STOP and ∼30 min for DHFR STOP (Fig. 1B).
Thus the FKBPDD and DHFRDD of the fusion proteins fold
independently of the SIINFEKL-eGFP and are stabilized by the
respective ligand.
Next, we compared the effect of DD ligand and the protea-
some inhibitor MG132 on protein levels. Addition of ligand for 4 h
increased GFP levels approximately fivefold for the STOP pro-
teins and approximately twofold for the NS proteins (Fig. 1C).
Combining DD ligand with MG132 did not result in a further
stabilization of the STOP proteins, but rather decreased their level
by ∼20%, as overall protein synthesis slowed after 1 h of protea-
some inhibition (38) (Fig. 1C and SI Appendix, Fig. S2). In con-
trast, NS protein GFP levels increased ∼18-fold upon combined
treatment with DD ligand and MG132 (Fig. 1C). Thus, for the NS
proteins, the majority of degradation is independent of the fold
stabilizing effect of ligand on their N-terminal domains, in contrast
to the turnover of the STOP proteins.
We next analyzed the effect of Listerin on protein levels. As
expected, deletion of Listerin was essentially without effect on
the levels of the STOP constructs (Fig. 1C). In contrast, the
steady-state levels of the NS proteins increased approximately
fivefold in the absence of Listerin (Fig. 1C). Notably, proteasome
inhibition further enhanced the levels of NS proteins (Fig. 1C).
This finding indicates that Listerin is not the only E3 ubiquitin
ligase that mediates NS protein degradation in human cells,
consistent with a recent report that, in yeast, the E3 ubiquitin
ligase Hul5 can mediate degradation of RQC substrates that escape
ubiquitylation by Ltn1 (39).
Degradation by RQC Results in Robust Antigen Presentation. To
compare the rate of antigen presentation of STOP and NS pro-
teins, we performed a kinetic analysis of FKBP and DHFR pre-
sentation in the HeLa.Kb WT background in the absence and
presence of DD ligand. Cells were stripped of surface antigens by
acid wash (40), and the appearance of MHC-I−bound SIINFEKL
peptide on the cell surface was monitored by antibody labeling and
flow cytometry. Total protein synthesis was concomitantly de-
termined by measuring intracellular GFP fluorescence after
blocking protein degradation with MG132 plus stabilizing ligand.
Presentation of the NS proteins in absolute terms was lower
than that of the respective STOP proteins, consistent with the
lower levels of NS protein being produced (Fig. 2A), as NS
mRNAs are sensed as defective and undergo silencing and/or
degradation (28, 41). We therefore normalized the presentation
rate in the linear range of the assay (1 to 3 h) to the rate of ex-
pression. The latter was estimated as the slope of GFP fluores-
cence in the presence of MG132 and DD ligand between 0 and 1 h
of culturing (Fig. 2B) to avoid stress-induced translational shut-
down due to proteasome inhibition (SI Appendix, Fig. S2). Ligand-
induced fold stabilization substantially reduced presentation for
the STOP proteins, but did not significantly affect presentation of
the NS proteins (Fig. 2C). In the absence of ligand, the expression-
normalized presentation of NS proteins can be similar to (DHFR)
or even approximately threefold higher (FKBP) than presentation
of the respective STOP proteins (Fig. 2C). Note that this difference
in relative presentation is due to the approximately fivefold-higher
presentation of DHFR STOP than FKBP STOP (P = 0.0002) in
the absence of ligand, which is consistent with the lower half-life of
the DHFRDD construct (Fig. 1B). Strikingly, in the presence of
ligand, the normalized presentation rate of both NS proteins was
substantially higher than that of the respective STOP proteins:
sixfold for FKBP and twofold for DHFR (Fig. 2C). Of note is that


























addition of ligand did not completely abrogate presentation of
STOP proteins, an observation we attribute to the small but de-
tectable turnover of stably folded protein (Fig. 1B) and the likely
possibility that a small fraction of the newly synthesized STOP
proteins will form defective species, in line with the DRiP hy-
pothesis. The highly efficient presentation of the NS proteins
compared to the basal level of STOP protein presentation (in the
presence of ligand) indicates that RQC represents a fast and robust
way to sample folding-efficient proteins. Thus, for proteins that
would otherwise evade degradation due to optimized folding, as is
often the case for viral proteins, the RQC pathway may provide an
effective mechanism for presentation.
To confirm the role of Listerin in NS protein presentation, we
expressed the NS fusion constructs in WT and Listerin-KO
HeLa.Kb cells, as well as in stably complemented Listerin-KO
cells (cKO). As expected, Listerin-KO cells had significantly
higher levels of NS proteins than Listerin-expressing cells (Fig. 3
and SI Appendix, Fig. S3). Conversely, presentation was signifi-
cantly higher in the Listerin-expressing cells (Fig. 3 and SI Appendix,
Fig. S3). Interestingly, neither degradation nor presentation of the
NS proteins was completely abolished in the Listerin-KO cells
(Fig. 3), consistent with the presence of an E3 ligase component(s)
functionally redundant to Listerin. Thus, the observed difference
in presentation between WT and Listerin-KO cells is likely to
underestimate the total contribution of the RQC pathway to
NS protein presentation.
Global Analysis of Listerin-Dependent Antigen Presentation. To in-
vestigate how RQC degradation affects the MHC-I peptide rep-
ertoire, we compared the immunopeptidome of WT and Listerin-
KO HeLa.Kb cells. To quantitatively profile the MHC-I−bound
peptides, MHC-I immunoprecipitations were performed from six
independent cultures of WT and Listerin-KO cells, and from two
cultures of cKO cells, followed by immunopeptide elution and
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WT (STOP) Listerin-KO (STOP) WT (NS) Listerin-KO (NS)
Fig. 1. Model STOP and NS constructs. (A) (Top) Model constructs used in this study. DDs, FKBPDD or DHFRDD, were fused to the antigenic peptide SIINFEKL
and eGFP. Each construct was created in two versions, STOP (normal translation termination) and NS, where translation proceeds into the 3′UTR and poly(A)
tail (encoding a polyK chain), resulting in ribosome stalling. (Bottom) Scheme depicting predicted effects of ligands on STOP and NS proteins. (B) Protein
stability of STOP constructs in the presence or absence of DD ligand, as measured by monitoring GFP fluorescence after inhibition of protein synthesis with
CHX. (C) Response of STOP and NS constructs (GFP fluorescence levels) to stabilizing ligand and proteasome inhibitor MG132 in WT and Listerin-KO cells. To
facilitate comparison, values are normalized to the maximum intensity obtained for the respective construct (ligand for STOP proteins, MG132+ligand for NS
proteins). In B and C, graphs show the average of three independent experiments, and error bars indicate SD.

































quantitation by label-free liquid chromatography (LC)-MS/MS
(Fig. 4A). In total, the analysis identified 3,658 peptides that
could be mapped to 2,016 proteins (Dataset S1) (42). The majority
of peptides were nine residues long, corresponding to the optimal
size for MHC-I binding (SI Appendix, Fig. S4). Unbiased motif
clustering of these peptides showed that the majority of sequences
fit into three clusters whose consensus motifs closely match the
binding patterns described for the MHC-I alleles present in
HeLa.Kb cells (SI Appendix, Fig. S4). One hundred three peptides
from 100 different proteins (∼3% of the detected immunopepti-
dome and ∼5% of presented proteins) were significantly (2- to
105-fold) more abundant in the WT cells than in Listerin-KO cells
(Fig. 4B), and therefore represent proteins for which RQC con-
tributes to antigen presentation. For the majority of these peptides
(91%), the average level of presentation was higher in cKO cells
than in Listerin-KO cells (Dataset S1) (42), despite incomplete
complementation (SI Appendix, Fig. S5). Moreover, hierarchical
clustering analysis showed that the datasets from Listerin-KO and
cKO cells separate into different subclusters (Fig. 4C), con-
firming that the observed differences are caused by the deletion
of Listerin.
RQC substrates are expected to include proteins lacking
C-terminal portions, depending on the site of translational stalling.
This implies that the C terminus of proteins might be un-
derrepresented in the group of Listerin-dependent immuno-
peptides. Analysis of the localization of the identified peptides
within their originating proteins showed that, when normalized
to total protein length, peptide positions for Listerin-dependent
and independent immunopeptides were not significantly differ-
ent (two-sided Mann−Whitney P = 0.551) (SI Appendix, Fig. S6).
However, the Listerin-dependent peptides tended to localize
to the center of proteins, being depleted not only from the
C terminus, as might have been expected, but also from the
N terminus (SI Appendix, Fig. S6).
To be able to distinguish between changes in presentation and
changes in expression resulting from the absence of Listerin, we
also measured the total proteome of the cell extracts used as
input for the MHC-I immunoprecipitation. Overall, the changes
in protein expression between WT and Listerin-KO cells were
limited (SI Appendix, Fig. S7A and Dataset S2) (42), although
some changes, albeit small, were statistically significant due to
the high number of biological replicates employed in the ex-
periment (SI Appendix, Fig. S7 A and B). While the total pro-
teome analysis did not identify any ubiquitin ligases with up-
regulated expression, multiple subunits of the exosome RNA
degradation machinery were more abundant in Listerin-KO cells
(SI Appendix, Fig. S7B and Dataset S2) (42), suggesting a partial
adaptation to the RQC defect. Normalization of immunopepti-
dome to proteome values demonstrated that, for the majority of
immunopeptides, the changes in presentation were not caused by
changes in protein expression (SI Appendix, Fig. S7C).
Further analysis of the group of proteins for which Listerin
contributes to presentation provided insights into the role of
RQC in antigen presentation. We first analyzed the Listerin
targets for their degradation kinetics, by comparing our immuno-
peptidome results with earlier degradation profiling data from
human epithelial cells by McShane et al. (43). According to this
study, 47% of proteins follow an exponential degradation (ED)
profile, where the degradation rate is constant over time (43). It
is assumed that, for this class of proteins, the degradation rate is
determined by the stability of the folded state (and other factors)
rather than by limited efficiency of de novo folding or assembly.
In contrast, a sizable number of proteins (9.4%) follow a non-ED
(NED) profile. These proteins are more likely to be degraded in
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Untreated Ligand MG132 + Ligand
Fig. 2. Time course of antigen presentation from model STOP and NS proteins. (A) GFP fluorescence and presentation (immunolabeling fluorescence [IF] of
surface H-2Kb:SIINFEKL complexes) levels in HeLa.Kb WT cells expressing the indicated NS and STOP proteins. At time 0, cells were stripped of immunopeptides
by acid wash, followed by addition of DD ligand and/or proteasome inhibitor to the cell culture medium. (B) Estimated protein expression of each construct,
based on the GFP accumulation in the presence of MG132+ligand during the first hour of treatment, that is, before onset of MG132-induced inhibition of
translation. (C) The presentation rate (slope in the linear range of the assay, 1 to 3 h) of each construct was normalized to the respective expression rate
(shown in B). All graphs show averages and SD (in arbitrary units) of three independent experiments. P values from two-sided t test are indicated. Asterisks
highlight statistically significant changes, *P < 0.05 and **P < 0.01.


























the first hours after synthesis (Fig. 4 D, Top) (43). This suggests
that proteins that follow NED have a lower chance of reaching
their mature form, and are at an increased risk of being recognized
as defective by the protein quality control machinery during fold-
ing and assembly. We found the antigenic peptides from proteins
with ED to be slightly underrepresented in the immunopeptidome
(41%) compared to the original dataset (47%, Fisher’s exact test
P = 0.0038), suggesting that they are more difficult to sample for
antigen presentation (Fig. 4 D, Bottom). However, ED proteins
were overrepresented in the group of Listerin targets, as compared
to proteins with Listerin-independent presentation (57% vs. 40%,
Fisher’s exact test P = 0.053). In contrast, NED proteins tended to
be less frequent among Listerin targets: While they represented
15% of Listerin-independent proteins, they accounted for only 6%
of the Listerin targets (Fig. 4D). In conclusion, RQC degradation
makes a measurable contribution to antigen presentation for
proteins with exponential decay kinetics (ED proteins) that are
characterized by efficient de novo folding and assembly. The
ability of RQC to target such proteins may facilitate early sampling
of viral proteins that have been evolutionarily selected for effective
folding and high stability.
Insights into RQC Degradation.Multiple causes of ribosome stalling
have been established, including premature polyadenylation of the
mRNA, the presence of stable secondary structure, or long
stretches of suboptimal codons in the mRNA (26, 29, 44–47).
While these studies have been performed with model substrates,
the endogenous targets of RQC degradation, and their underlying
defects, remain largely unknown. Gene ontology (GO) enrich-
ment analysis did not show any significant differences between the
group of Listerin targets and the entire immunopeptidome data-
set. In accordance, proteins with different cellular locations dis-
played similar WT/Listerin-KO immunopeptidome presentation
ratios (ANOVA P = 0.11; Fig. 5A). These observations highlight
an important feature of RQC degradation—that it is not biased
toward a specific molecular function, cellular component, or bi-
ological process. However, the Listerin targets identified by the
immunopeptidome analysis were significantly larger in size than
proteins with Listerin-independent presentation (median length of
623 and 513 amino acids, respectively, two-sided Mann−Whitney
P = 0.024; SI Appendix, Fig. S6B). A possible explanation is that
protein length correlates with mRNA complexity features, such as
number of introns or secondary structure, which could render
transcription and mRNA maturation more error-prone, and
consequently more prone to ribosome stalling.
To gain insight into the natural causes for RQC degradation,
we next asked whether the Listerin targets were more frequently
subjected to premature mRNA polyadenylation, that is, the er-
roneous cleavage of the mRNA and poly(A) insertion within the
coding sequence (internal polyadenylation), which leads to loss
of the termination codon, poly(A) translation, and ribosomal
stalling (35, 36). A quantitative measurement of poly(A) sites in
transcripts of HeLa cells is provided by the PolyA_DB database
(48, 49). Accordingly, the frequency of poly(A) sites inside the
coding sequence tended to be higher among the Listerin tar-
gets than in the group of proteins where no effect of Listerin
knockout on presentation was observed: 46% and 36%, re-
spectively (Fig. 5B) (Fischer’s exact test P = 0.072). Furthermore,
the position of Listerin-dependent immunopeptides in the
mRNA tended to be more frequently 5′ relative to premature
poly(A) site(s) than the position of Listerin-independent pep-
tides (56% and 47%, respectively; Fig. 5B). Given the number of
different RNA defects that have been demonstrated to cause
ribosome stalling, one can predict the group of RQC substrates
to be very heterogeneous. We therefore did not expect strong
effects when analyzing traits correlating with the observed
immunopeptidome changes. The fact that we could nonetheless
observe an association of Listerin-dependent presentation with
premature poly(A) sites supports the notion that internal poly-
adenylation is an important source of RQC substrates in vivo.
An interesting observation provided by the total proteome
analysis of the HeLa.Kb Listerin-KO cell line was the GO term
enrichment for “ER membrane protein complex” (EMC) and
“mitochondrial outer membrane translocase complex” (TOM)
among the up-regulated proteins in the Listerin-KO cells (SI
Appendix, Fig. S7B). Of the nine detected EMC subunits, five
showed a significant (P < 0.008) increase in protein abundance in
the Listerin-KO cells. For the TOM complex, four out of the nine
quantified subunits were increased (Fig. 5C and Dataset S2) (42).
The EMC and TOM complexes have been implicated in the
process of cotranslational insertion of transmembrane proteins
into the ER and mitochondria, respectively (50–53). Prompted by
this finding, we analyzed the proteins identified in the immuno-
peptidome for the presence of transmembrane domains (TMDs)
using the Phobius transmembrane topology prediction server (54,
55). Transmembrane proteins in general (number of TMDs ≥1)
were not overrepresented among the Listerin targets (Fig. 5D).
However, there was a clear tendency for the enrichment of pro-
teins with large numbers (>10) of TMDs: 4% of the Listerin
targets versus 1.5% among proteins with Listerin-independent
presentation (Fischer’s exact test P = 0.073). In agreement, pro-
teins with more than 10 TMDs displayed significantly higher WT/
Listerin-KO immunopeptidome ratios than proteins not having
any predicted TMD (Fig. 5D). Of note, proteins with >10 TMDs
had also higher WT/Listerin-KO immunopeptidome ratios than
randomly selected soluble (TMD n = 0) proteins of equal size (SI
Appendix, Fig. S8). Thus, larger size alone does not explain the
higher Listerin-dependent presentation of proteins with multiple
TMDs. In conclusion, a high number of TMDs correlates with an
increased propensity to undergo RQC degradation.
Protein level (GFP intensity)A
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Fig. 3. Effect of Listerin on presentation of STOP and NS proteins. (A) Mean
fluorescence intensity (in arbitrary units) of protein (GFP intensity) and (B)
presentation (H-2Kb:SIINFEKL immunolabeling intensity) levels of NS pro-
teins transiently transfected in the HeLa.Kb WT, Listerin-KO, and com-
plemented cKO cell lines, in the presence of folding ligand. See SI Appendix,
Fig. S3 for representative flow cytometry plots and gating parameters. P
values are from two-sided paired t test of three independent experiments.
Asterisks highlight statistically significant changes, *P < 0.05 and **P < 0.01.

































Closer inspection of the group of Listerin targets revealed five
proteins belonging to the solute carrier (SLC) family of membrane
transport proteins (Fig. 5E). These proteins have 10 to 12
TMDs and no predicted N-terminal signal peptide sequence,
and are annotated as being localized at the plasma membrane
[although one of them, SLC41A3, has been reported to localize
to the mitochondrial membrane (56)]. The EMC has been
shown to be involved in the biogenesis of a range of multipass
transmembrane proteins, with a particular enrichment for
transporters (51). Thus, the Listerin-dependent representation
of multipass membrane proteins in the immunopeptidome
likely reflects a role of the RQC in quality control during the
cotranslational insertion of such proteins into the ER and/or
mitochondrial membranes.
Discussion
In this study, we have analyzed the capacity of the RQC ma-
chinery in producing epitopes for MHC class I-mediated antigen
presentation. According to the DRiP hypothesis (7), antigen
presentation relies on the fast degradation of newly synthesized
proteins that fail to reach their structurally mature, functional
state. DRiPs can arise from deficiencies during protein trans-
lation, folding, and assembly (Fig. 6). Folding represents an in-
tricate process requiring proteins to navigate a complex energy
landscape, putting them at risk for adopting nonnative structures
(57). Because misfolded proteins can form toxic aggregates,
newly synthesized proteins are subjected to extensive scrutiny by
quality control pathways that survey structural cues and target
failed proteins to proteasomal degradation (Fig. 6). Folding er-
rors are thought to be exploited by the adaptive immune system
in generating antigenic peptides (11, 58). This implies that proteins
having acquired highly efficient folding and maturation processes
might evade presentation, including viral proteins that are under
intense evolutionary pressure. Our results demonstrate that stall-
ing during translation generates DRiPs whose degradation by the
RQC pathway gives rise to efficient antigen presentation. RQC is
unique in that degradation rates are largely independent of the
folding state of its substrates, as shown here using NS protein
constructs containing structurally unstable FKBP or DHFR do-
mains. While addition of stabilizing ligand had only a minor
effect on degradation and did not reduce presentation rates of







































































































































Fig. 4. Immunopeptidome analysis of HeLa.Kb WT and Listerin-KO cells. (A) General workflow of immunopeptidome analysis. After cell lysis, an aliquot of
the total cell extract was digested with trypsin and used for total proteome analysis (Dataset S2 and SI Appendix, Fig. S7). The majority of the cell extract was
submitted to immunoprecipitation of human and mouse MHC-I complexes. MHC-I−bound peptides were then eluted at low pH, followed by LC-MS/MS
analysis. (B) Volcano plot showing changes in MHC-I−bound peptide abundance between WT and Listerin-KO cells. Peptides for which Listerin made a
significant contribution to presentation (WT > KO, 103 peptides) are marked in red. (C) Hierarchical clustering analysis of Listerin-dependent peptides, in-
cluding the cKO controls. Note that, due to partial rates of complementation (SI Appendix, Fig. S5), full WT levels were not reached in the cKO cells. (D) (Top)
Diagram showing the characteristic decay profiles of exponentially (ED) and nonexponentially (NED) degraded proteins, according to McShane et al. (43).
(Bottom) Frequency of different profiles of degradation kinetics (exponential, nonexponential, undefined) in groups of proteins with Listerin-dependent
(highlighted with red outline) and independent presentation. Only proteins with available information on degradation kinetics (43) were considered (726
proteins of the 2,016 proteins characterized in the immunopeptidome analysis, 684 Listerin-independent and 35 Listerin-dependent targets).


























and presentation of the corresponding STOP proteins. Thus,
the RQC pathway could be particularly important in antigen
presentation from proteins that circumvent folding-dependent
quality control due to their efficient folding and maturation
properties (Fig. 6).
Because RQC degradation occurs very early in protein bio-
synthesis (Fig. 6), it allows fast sampling for antigen presentation.
Kinetic analysis of presentation showed that, for proteins reaching
a stably folded state (in the presence of ligand), the presentation
rate obtained for RQC-mediated degradation (NS protein) can be
sixfold higher than presentation obtained from its intrinsic syn-
thesis error and turnover (STOP protein). Strikingly, even for a
folding-compromised protein, such as FKBP STOP in the absence
of ligand, RQC can still result in an approximately threefold faster
presentation rate, reflecting a major kinetic advantage of RQC
over posttranslational quality control (Fig. 6).
Our immunopeptidome analysis of Listerin-deficient cells
showed that RQC indeed contributes to the MHC-I repertoire.
We identified 103 peptides with significantly reduced presentation
(2- to 105-fold) in the absence of Listerin. These peptides repre-
sent a relatively small (∼3%) fraction of the quantified dataset.
However, our experiments with model proteins (Fig. 1) indicate
that Listerin is not the only ubiquitin ligase responsible for deg-
radation of ribosome-stalled nascent chains. Moreover, the total
proteome analysis of Listerin-KO cells showed an up-regulation of
RNA degradation machinery, which may reduce the amount of
RQC substrates. For these reasons, our analysis is likely to un-











































































































































































































































































Pep. position to int. poly(A)
Fig. 5. Properties of proteins associated with RQC degradation and presentation. (A) WT/Listerin-KO averaged immunopeptidome ratios for MHC-I pre-
sented proteins grouped according to their subcellular location annotated in Uniprot. (A and D) In the Tukey box plots, solid horizontal lines correspond to
25th to 75th percentiles and median value, whisker caps indicate 1.5 interquartile distance, and individual data points indicate outliers. (B) (Left) Frequency of
proteins/genes having at least one detectable poly(A) site inside the protein coding sequence. Only proteins for which information was available in the
poly(A)_DB were considered: 1,686 proteins with presented peptides, 1,597 Listerin-independent and 79 Listerin targets (red outline). (Right) Frequency of
immunopeptides classified according to their localization in the mRNA in relation to internal polyadenylation site(s): 5′ to all poly(A) site(s), between (peptide
is localized in between the first and the last internal poly(A), in cases where multiple internal sites have been identified for the same gene), and 3′ (peptide is
encoded 3′ to all internal poly(A) site(s)). Only peptides mapped to internal polyadenylation-containing genes (according to the polyA_DB) were considered:
1,451 peptides in total, 1,412 Listerin-independent and 36 Listerin-dependent (red outline). (C) Total proteome analysis of Listerin-KO cells (as in SI Appendix,
Fig. S7) with EMC and TOM complex proteins highlighted in red and purple, respectively. The subunits significantly increased in the KO cells are labeled.
(D) (Left) Frequency of proteins with different numbers of TMDs, according to the Phobius predictor. (Right) Averaged immunopeptidome WT/KO ratios
of proteins grouped according to the number of TMDs. P value: ANOVA with Dunnett test in relation to TMD = 0. ANOVA test for trend also shows higher
tendency for Listerin effect in groups with increasing number of TMDs (left to right groups, P = 0.0015). (E) Immunopeptidome results (as in Fig. 4B), with
Listerin-dependent peptides derived from multispanning membrane proteins marked in red. The corresponding gene names are indicated. Asterisks highlight
statistically significant changes, *P < 0.05 and **P < 0.01.

































Nevertheless, the immunopeptidome results provide support
for the prediction that RQC is preferentially important for
improving the presentation of proteins that have a high pro-
pensity to reach a folded mature state (identified here as pro-
teins with ED).
As MHC-I presentation should reflect proteasomal degrada-
tion, the immunopeptidome can be used as a powerful screening
tool for RQC substrates. Limitations of this approach include the
dilution of the RQC effect for proteins that are highly degraded by
other pathways, and the possibility that certain truncated RQC
substrates might lack immunogenic peptides. Notably, our data
support a role of premature polyadenylation in generating en-
dogenous RQC substrates, consistent with current understanding
(49, 59, 60). Interestingly, our analysis also identified several multi-
pass transmembrane proteins as RQC substrates, along with an
up-regulation of the EMC and TOM membrane insertion ma-
chineries in RQC-deficient cells. A recent study mapping EMC
substrates by proximity-specific ribosome profiling reported that
EMC binds to proteins whose ERmembrane insertion represents a
challenge due to the high number of TMDs and/or the presence of
charged residues in the membrane-spanning segments (51). These
are structural features shared by the members of the SLC family of
transport proteins we identified as Listerin targets. It seems plau-
sible, therefore, that the up-regulation of membrane insertion
machinery is an adaptation to the presence of insertion-stalled SLC
(and other TMD) proteins in Listerin-deficient cells. Indeed, it is
known that Listerin can ubiquitylate nascent polypeptides stalled at
the Sec61 translocon of the ER membrane (61, 62). In principle,
ribosome stalling during membrane translocation could be trig-
gered by the same mRNA defects engaging the RQC in the cytosol
(61). However, proteins with low numbers of TMD domains (and
secretory proteins in general) were not identified as preferential
RQC substrates. This suggests that stalling in the case of the SLC
proteins takes place as a result of the difficult-to-insert nature of
these multipass proteins, rather than due to mRNA defects. As-
suming a link between membrane translocation and ribosomal
elongation, improper membrane insertion could result in stalling
of the membrane-anchored ribosome, in turn leading to ribosome
collision, a trigger of RQC recruitment (49). This mechanism
would ensure degradation of substrates that might otherwise es-
cape ERAD, as in the case of truncated proteins that acquire
sufficient folding (61). Another possibility is that the mRNAs
encoding multispanning transmembrane proteins represent targets


































































Fig. 6. MHC-I antigen presentation during protein synthesis and turnover. The process of protein biosynthesis (left column) leading to stable, functional
protein comprises multiple steps. Errors may result in DRiPs, which are targeted for ubiquitin-dependent proteasomal degradation and therefore can sample
newly synthesized proteins for antigen presentation. The RQC pathway (top gray panel) functions to degrade stalled polypeptide chains in a manner in-
dependent of their folding state. This situation mainly arises from errors in mRNA synthesis and maturation. Our results suggest that failed cotranslational
insertion into membranes of proteins with multiple transmembrane segments also causes stalling and triggers RQC-mediated degradation. Folding-
dependent protein quality control pathways survey structural cues to identify errors in protein folding and assembly as well as mature protein damage
(lower gray panel).


























the burden of ER protein synthesis during stress situations, Ire1
cleaves ER-localized mRNAs at specific sites within the coding
sequence. This results in mRNA species lacking stop codons and
poly(A) tails (65), which are likely to cause ribosome stalling.
It is noteworthy, in this context, that flaviviruses such as Zika and
Dengue translate their genome into a single multipass trans-
membrane protein at the ER, which is later cleaved into 10 different
proteins (66). Accordingly, these viruses were shown to require the
EMC during the early stages of replication (67, 68). The observed
trend for multipass transmembrane proteins among RQC substrates
may thus facilitate the early detection of these viral infections.
Materials and Methods
Purification of MHC-I Peptides. Immunopeptidome analysis was performed
with six large independent cultures of HeLa.Kb WT and Listerin-KO, and two
cultures of the stably complemented KO control cell line. Cells were grown
in Nunc Cell Factory Systems (Thermo Scientific) of 2,528 cm2 culture surface.
After reaching a semiconfluent state, cells were harvested with TrypLE Ex-
press Enzyme and washed twice in phosphate-buffered saline (PBS), and dry
pellets were flash frozen and stored at −80 °C until further use. The yields
per culture ranged from 2.9 × 108 to 4.3 × 108 cells (3.7 × 108 on average).
MHC-I complex immunoprecipitation and peptide ligand purification were
performed as previously described (69). Briefly, cell pellets were resuspended
in 8 mL of PBS with 0.25% sodium deoxycholate (Sigma-Aldrich), 1% octyl-β-D
glucopyranoside (Sigma-Aldrich), 0.2 mM iodoacetamide, 1 mM (ethylenedinitrilo)
tetraacetic acid, and 1:200 Protease Inhibitor Mixture (Sigma-Aldrich) and lysed
at 4 °C for 1 h. The lysates were then cleared by centrifugation at 40,000 × g at
4 °C for 30 min. MHC-I immunoaffinity purification was performed on the
cleared lysate with 2 mg of the panHLA-I antibody W6/32 (purified from HB95
cells; ATCC) covalently bound to protein-A Sepharose beads (Invitrogen), and
MHC-I complexes were eluted at room temperature with 0.1 N acetic acid. The
eluted molecules were then loaded on Sep-Pak tC18 cartridges (Waters), and
the MHC-I peptides were separated from the MHC-I complexes by eluting them
with 30% acetonitrile (ACN) in 0.1% trifluoroacetic acid (TFA). Peptides were
then further purified using Silica C-18 column tips (Harvard Apparatus), eluted
again with 30%ACN in 0.1% TFA, and concentrated by vacuum centrifugation.
Finally, MHC-I peptides were resuspendedwith 2%ACN in 0.1% TFA for single-
shot LC-MS/MS analysis. Additional experimental procedures are described in
SI Appendix.
Data Availability. All data are contained in the main text, SI Appendix, or
Datasets S1 and S2. The MS proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE (70) partner repository with the
dataset identifier PXD014644. Any further details are available upon request.
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